StockIQ.techPfizer Inc. (PFE) Stock Analysis
Free AI-powered analysis and research for Pfizer Inc. stock
Sector: Healthcare
PFE snapshot
Data as of 4 Nov 2026 close. Updated daily.
Pfizer Inc. scores 70/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 94% of its 52-week range, up 26.0% over the past year. Latest reported figures show a profit margin of 6.8%, return on equity of 5.0% and revenue growth of +2.6%.
What is driving the score
- Strong Uptrend: +12
- MACD Bullish: +8
- High P/E (40.2): -10
- Weak Liquidity (1.27 Current Ratio): -5
- Strong Long-term Uptrend: +8
- Healthy Momentum (+26.0% over 1 year): +7
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full PFE report
Pfizer Inc. (PFE) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze PFE Now →📰 Latest Update
Pfizer Just Raised Guidance. The Bigger Test Comes Next
Wed, November 4, 2026 at 5:08 PM UTC 2 min read
Pfizer Inc. (PFE) raised its full-year guidance after third-quarter profits surpassed expectations, driven by new drugs and cost reductions. The company reported revenue of $16.6 billion and adjusted profits of $0.87 per share, with a 32 percent increase in revenue from new products. Looking ahead, Pfizer forecasts sales of $62 billion to $64 billion in 2026, while management highlighted potential challenges from patent expirations and U.S. medication pricing changes.